Overview

A Study Of The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of a new allergy medication
Phase:
Phase 2
Details
Lead Sponsor:
Bausch & Lomb Incorporated
Treatments:
Ketotifen
Vasoconstrictor Agents